Skip to Content

INCY 5 (Jakafi 5 mg)

Generic Name: ruxolitinib

Pill with imprint INCY 5 is White, Round and has been identified as Jakafi 5 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of myelofibrosis; polycythemia vera; graft-versus-host disease; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for INCY 5

Jakafi

Generic Name
ruxolitinib
Imprint
INCY 5
Strength
5 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Incyte Corporation
National Drug Code (NDC)
50881-0005
Inactive Ingredients
microcrystalline cellulose, lactose monohydrate, silicon dioxide, hydroxypropyl cellulose (type e), povidone, sodium starch glycolate type A potato, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "INCY 5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.